Market closed

Corbus Pharmaceuticals Holdings, Inc./$CRBP

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Ticker

$CRBP
Trading on

Industry

Biotechnology

Employees

28

CRBP Metrics

BasicAdvanced
$61M
-
-$3.68
2.63
-
$61M
2.63
$7.88
$4.67
12.944
12.613
1.147
2.274
-26.03%
-33.07%
-59.34%
0.43
0.43
-1.311
-64.26%
-30.86%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CRBP

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Corbus Pharmaceuticals Holdings, Inc. stock?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a market cap of $61M as of April 06, 2025.

What is the P/E ratio for Corbus Pharmaceuticals Holdings, Inc. stock?

The price to earnings (P/E) ratio for Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock is 0 as of April 06, 2025.

Does Corbus Pharmaceuticals Holdings, Inc. stock pay dividends?

No, Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock does not pay dividends to its shareholders as of April 06, 2025.

When is the next Corbus Pharmaceuticals Holdings, Inc. dividend payment date?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock does not pay dividends to its shareholders.

What is the beta indicator for Corbus Pharmaceuticals Holdings, Inc.?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) has a beta rating of 2.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.